Clostridium difficile is a bacterial pathogen that is the leading cause of nosocomial antibiotic-
associated diarrhea and pseudomembranous colitis worldwide. The incidence, severity …

Clostridium difficile infection (CDI) has significant clinical impact especially on the elderly
and/or immunocompromised patients. The pathogenicity of Clostridium difficile is mainly …

Whereas some rare lipids contribute to the identity of cell organelles, we focus on the
abundant lipids that form the matrix of organelle membranes. Observations using bioprobes …

Phosphatidylserine (PS) is a quantitatively minor membrane phospholipid that is
synthesized by prokaryotic and eukaryotic cells. In this review we focus on genes and …

Toxins A and B, which are the major virulence factors of antibiotic-associated diarrhea and
pseudomembranous colitis caused by Clostridium difficile, are the prototypes of the family of …

Clostridium difficile is a toxin-producing bacterium that is a frequent cause of hospital-
acquired and antibiotic-associated diarrhea. The incidence, severity, and costs associated …

Clostridia produce the highest number of toxins of any type of bacteria and are involved in
severe diseases in humans and other animals. Most of the clostridial toxins are pore-forming …

Clostridium difficile is an opportunistic pathogen that establishes in the colon when the gut
microbiota are disrupted by antibiotics or disease. C. difficile infection (CDI) is largely …

Clostridium difficile causes pseudomembranous colitis and is responsible for many cases of
nosocomial antibiotic-associated diarrhea. Major virulence factors of C. difficile are the …

Clostridium sordellii infections pose difficult clinical challenges and are usually fatal. Most
commonly, these infections occur after trauma, childbirth, and routine gynecological …